Registrant Detail

Registration

• Licence Type:Restricted Licence
• Start Date: 01 Jan 2020
• End Date:
• Licence Type:Clinical Assessment Licence
• Start Date: 09 Sep 2019
• End Date:29 Nov 2019
• Interim Measure:Suspension
• Start Date: 23 Feb 2016
• End Date:05 Sep 2019
• Interim Measure:Suspension
• Start Date: 21 Aug 2015
• End Date:08 Sep 2015
• Licence Type:Full Licence
• Start Date: 15 Dec 2009
• End Date:31 Dec 2016
• Licence Type:Defined Licence
• Start Date: 03 Nov 2009
• End Date:15 Dec 2009
• Licence Type:Educational Licence
• Start Date: 09 Jun 2008
• End Date:30 Sep 2009
• Licence Type:Educational Licence
• Start Date: 01 Jul 2007
• End Date:13 May 2008

Postgraduate training

• Type:Residency
• Discipline:Family Medicine
• Training Facility: Dalhousie
• From:2007
• To:2009

• Decision date: 26 Jun 2019

• Announcement of disciplinary decision:

  The College of Physicians and Surgeons of Nova Scotia hereby gives notice that as a result of a complaint and pursuant to the Nova Scotia Medical Act, the Hearing Committee of the College approved a Settlement Agreement on June 26, 2019, with reasons to follow. Those reasons have now been issued and are available in the Committee’s written decision accessible below. The Settlement Agreement contains Dr. Jones’ admissions of professional misconduct, incompetence and incapacity. The Settlement Agreement also contains agreed upon sanctions including a 36 month suspension, strict conditions to be met before Dr. Jones may return to practice and extensive conditions and restrictions on Dr. Jones’ practice when she does return. The Settlement Agreement is included as a Schedule to the Hearing Committee written decision. ***UPDATE MARCH 17, 2022*** By letter dated March 8, 2022, and with the agreement of Dr. Jones and the College, the Hearing Committee lifted the restriction set out in paragraph 126(g)(iii) of the Settlement Agreement. As such, the prior restriction preventing Dr. Jones from prescribing benzodiazepines, and zoplicone, zaleplon or additional members of this class of drugs that may emerge (collectively the “Z-drugs”) is lifted effective March 8, 2022. View further decision details

• Condition:Will not prescribe narcotics (Controlled Drugs and Substance Act Schedule I) or cannabis (Controlled Drugs and Substance Act Schedule II).
• Condition:Will not practice as a sole practitioner (in an office with no other practising physicians).
• Condition:Must post a College sign in the waiting room and examination rooms advising patients of prescribing restriction.

• Not Available